Oramed Pharmaceuticals Ownership | Who Owns Oramed Pharmaceuticals?

Oramed Pharmaceuticals Ownership Summary

Oramed Pharmaceuticals is owned by 41.07% institutional investors, 17.65% insiders, and 41.28% retail investors. Mercer global advisors inc /adv is the largest institutional shareholder, holding 4.61% of ORMP shares. iShares Russell 2000 ETF is the top mutual fund, with 1.98% of its assets in Oramed Pharmaceuticals shares.

ORMP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Oramed Pharmaceuticals	41.07%	17.65%	41.28%
Sector	Healthcare Stocks	246.48%	12.12%	-158.60%
Industry	Biotech Stocks	384.82%	11.76%	-296.58%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Mercer global advisors inc /adv	1.91M	4.61%	$6.50M
Gem investment advisors	1.64M	3.96%	$5.58M
Murchinson	1.32M	3.18%	$4.47M
Bml capital management	884.39K	2.15%	$4.13M
Boothbay fund management	600.72K	1.45%	$2.04M
Geode capital management	500.92K	1.22%	$2.34M
Marshall wace, llp	259.61K	0.63%	$882.68K
Rathbones group	233.02K	0.56%	$792.26K
Dimensional fund advisors lp	211.25K	0.51%	$986.61K
Strs ohio	188.50K	0.46%	$880.29K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Gem investment advisors	1.64M	5.48%	$5.58M
Bml capital management	884.39K	2.20%	$4.13M
Murchinson	1.32M	0.57%	$4.47M
Sage capital management	17.98K	0.03%	$61.13K
Boothbay fund management	600.72K	0.03%	$2.04M
Glass jacobson investment advisors	10.54K	0.02%	$49.22K
Mercer global advisors inc /adv	1.91M	0.01%	$6.50M
Prelude capital management	35.31K	0.01%	$120.06K
Hillsdale investment management	97.30K	0.01%	$330.82K
Pioneer family office	3.00K	0.01%	$14.01K

Top Buyers

Holder	Shares	% Assets	Change
Mercer global advisors inc /adv	1.91M	0.01%	1.91M
O'shaughnessy asset management	116.36K	0.00%	116.36K
Susquehanna group, llp	136.22K	0.00%	110.23K
Hillsdale investment management	97.30K	0.01%	97.30K
Strs ohio	188.50K	0.00%	54.70K

Top Sellers

Holder	Shares	% Assets	Change
Gem investment advisors	1.64M	5.48%	-358.73K
Two sigma advisers, lp	-	-	-213.00K
Bank of america corp /de/	173.24K	-	-113.81K
Citadel advisors	98.63K	0.00%	-97.39K
Peapod lane capital	-	-	-84.78K

New Positions

Holder	Shares	% Assets	Change	Value
Mercer global advisors inc /adv	1.91M	0.01%	1.91M	$6.50M
O'shaughnessy asset management	116.36K	0.00%	116.36K	$395.63K
Hillsdale investment management	97.30K	0.01%	97.30K	$330.82K
Hudson bay capital management lp	51.67K	0.00%	51.67K	$175.68K
Bailard	32.48K	0.00%	32.48K	$110.42K

Sold Out

Holder	Change
Innealta capital	-13.00
Mather group, llc.	-100.00
Global retirement partners	-100.00
Hopwood financial services	-200.00
Beacon capital management	-219.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	86	34.38%	16,857,038	27.31%	41	3.89%	51	45.71%	19	18.75%
Mar 31, 2026	35	-37.50%	4,617,647	-58.24%	11	1.59%	19	-26.92%	8	-20.00%
Dec 31, 2025	35	-25.53%	6,592,201	-28.42%	15	3.24%	14	-12.50%	6	-25.00%
Sep 30, 2025	44	-4.35%	7,236,076	1.46%	17	5.70%	15	50.00%	8	-46.67%
Jun 30, 2025	48	-11.11%	7,251,754	-6.69%	17	4.91%	11	-42.11%	15	-16.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Russell 2000 ETF	821.82K	1.98%	-
Fidelity Small Cap Index	378.48K	0.91%	-
iShares Russell 2000 Value ETF	318.36K	0.77%	-
Russell 2000 Equity Index Fund B	204.87K	0.50%	204.87K
Russell 2000 Index Non-Lendable Fund	204.87K	0.50%	204.87K
Vanguard Russell 2000 ETF	202.58K	0.49%	6.13K
State St Russell Sm Cap® Idx SL Cl I	126.50K	0.30%	-
iShares Micro-Cap ETF	107.39K	0.26%	-
Schwab Small Cap Index	83.63K	0.20%	-
NT R2000 Index Fund - NL	77.32K	0.19%	77.32K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 01, 2026	Gabay Avraham	Chief Financial Officer	Sell	$90.20K
Oct 01, 2026	Hexter Joshua	COO & CBO	Sell	$135.33K
Jul 01, 2026	Hexter Joshua	COO & CBO	Sell	$611.43K
Jul 01, 2026	Gabay Avraham	Chief Financial Officer	Sell	$330.74K
Apr 04, 2023	Mayer Arie	-	Buy	$8.40K

Insider Transactions Trends

Date	Buy	Sell
2026 Q4	-	2
2026 Q3	-	2
2026 Q1	-	-
2025 Q4	-	-
2025 Q2	-	-

ORMP Ownership FAQ

Who Owns Oramed Pharmaceuticals?

Oramed Pharmaceuticals shareholders are primarily institutional investors at 41.07%, followed by 17.65% insiders and 41.28% retail investors. The average institutional ownership in Oramed Pharmaceuticals's industry, Biotech Stocks , is 384.82%, which Oramed Pharmaceuticals falls below.

Who owns the most shares of Oramed Pharmaceuticals?

Oramed Pharmaceuticals’s largest shareholders are Mercer global advisors inc /adv (1.91M shares, 4.61%), Gem investment advisors (1.64M shares, 3.96%), and Murchinson (1.32M shares, 3.18%). Together, they hold 11.75% of Oramed Pharmaceuticals’s total shares outstanding.

Does Blackrock own Oramed Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Oramed Pharmaceuticals.

Who is Oramed Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Gem investment advisors is Oramed Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.48% of its assets in 1.64M Oramed Pharmaceuticals shares, valued at 5.58M$.

Who is the top mutual fund holder of Oramed Pharmaceuticals shares?

iShares Russell 2000 ETF is the top mutual fund holder of Oramed Pharmaceuticals shares, with 1.98% of its total shares outstanding invested in 821.82K Oramed Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools